300. IgG4関連疾患 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 40 / 薬物数 : 47 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141
薬物ごとの開発者(Primary Sponsor)、臨床試験情報(抜粋)です。
18F-FDG
Peking Union Medical College Hospital
2012 Early Phase 1 NCT01665196 China;
68Ga-FAPI
Peking Union Medical College Hospital
2019 Early Phase 1 NCT04125511 China;
Abatacept
Massachusetts General Hospital
2018 Phase 2 NCT03669861 United States;
Acetaminophen
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Afucosylated IgG1 kappa monoclonal antibody
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Viela Bio, Inc.
2021 Phase 3 EUCTR2020-000417-33-SE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000417-33-NL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-PL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-HU Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-DE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Biliary stent
Peking Union Medical College Hospital
2016 - NCT02797665 China;
CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Corticosteroids
Peking Union Medical College Hospital
2016 - NCT02797665 China;
Diphenhydramine
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Drug free, IS monotherapy and GC combined with IS
Peking Union Medical College Hospital
2019 - NCT04124861 -
Elotuzumab
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Extra blood draw samples
Assistance Publique Hopitaux De Marseille
2012 - NCT02899039 France;
Famotidine
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Glucocorticoids
Principia Biopharma, a Sanofi Company
2020 Phase 2 NCT04520451 Canada;United States;
Inebilizumab
Katayama Sota
2021 Phase 3 JPRN-jRCT2071210001 Argentina;Australia;Canada;China;France;Germay;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;UK;USA;Ukraine;
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Viela Bio
2020 Phase 3 NCT04540497 Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Leflunomide
Chinese PLA General Hospital
2016 Phase 4 NCT02703194 China;
Lenalidomide
Mayo Clinic
2016 Phase 1 NCT02705638 United States;
METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Mayo Interactive Breath Hold Monitor
Mayo Clinic
2006 - NCT00588367 United States;
Methionine
Saitama Medical University International Medical Center
2016 - JPRN-UMIN000019908 Japan;
Methylprednisolone
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Perflubutane
Department of EndoscopyThe Jikei University School of Medicine
2018 - JPRN-UMIN000030735 Japan;
Prednisolone
Department of Gastroenterology, University of Tokyo
2010 - JPRN-UMIN000003804 Japan;
Osaka University
2016 - JPRN-UMIN000022633 Japan;
Prednisone
Chinese PLA General Hospital
2016 Phase 4 NCT02703194 China;
Katayama Sota
2021 Phase 3 JPRN-jRCT2071210001 Argentina;Australia;Canada;China;France;Germay;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;UK;USA;Ukraine;
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Peking Union Medical College Hospital
2012 Phase 2/Phase 3 NCT01758393 China;
Prednisone and Belimumab
Peking Union Medical College Hospital
2021 Phase 4 NCT04660565 China;
Prednisone and Mycophenolate mofetil
Peking Union Medical College Hospital
2015 Phase 2 NCT02458196 China;
Rilzabrutinib
Principia Biopharma, a Sanofi Company
2020 Phase 2 NCT04520451 Canada;United States;
Rituximab
Massachusetts General Hospital
2012 Phase 1/Phase 2 NCT01584388 United States;
Mayo Clinic
2016 Phase 1 NCT02705638 United States;
T 614
Wen Zhang
2017 Phase 4 NCT03368274 China;
Thalidomide
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
2020 Phase 4 ChiCTR2000028918 China;
Uplizna
Viela Bio, Inc.
2021 Phase 3 EUCTR2020-000417-33-SE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000417-33-NL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-PL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-DE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
XmAb5871
Xencor INC
2019 Phase 3 EUCTR2017-002214-31-IT Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;United States;
Xencor, Inc.
2016 Phase 2 NCT02725476 United States;
Zanubrutinib
Matthew C. Baker
2022 Phase 2 NCT04602598 United States;
Peking Union Medical College Hospital
2012 Early Phase 1 NCT01665196 China;
68Ga-FAPI
Peking Union Medical College Hospital
2019 Early Phase 1 NCT04125511 China;
Abatacept
Massachusetts General Hospital
2018 Phase 2 NCT03669861 United States;
Acetaminophen
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Afucosylated IgG1 kappa monoclonal antibody
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Viela Bio, Inc.
2021 Phase 3 EUCTR2020-000417-33-SE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000417-33-NL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-PL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-HU Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-DE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Biliary stent
Peking Union Medical College Hospital
2016 - NCT02797665 China;
CETIRIZINA SANDOZ - 10 MG COMPRESSE RIVESTITE CON FILM 20 COMPRESSE IN BLISTER PVC/ALU
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Corticosteroids
Peking Union Medical College Hospital
2016 - NCT02797665 China;
Diphenhydramine
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Drug free, IS monotherapy and GC combined with IS
Peking Union Medical College Hospital
2019 - NCT04124861 -
Elotuzumab
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Extra blood draw samples
Assistance Publique Hopitaux De Marseille
2012 - NCT02899039 France;
Famotidine
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Glucocorticoids
Principia Biopharma, a Sanofi Company
2020 Phase 2 NCT04520451 Canada;United States;
Inebilizumab
Katayama Sota
2021 Phase 3 JPRN-jRCT2071210001 Argentina;Australia;Canada;China;France;Germay;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;UK;USA;Ukraine;
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Viela Bio
2020 Phase 3 NCT04540497 Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
Leflunomide
Chinese PLA General Hospital
2016 Phase 4 NCT02703194 China;
Lenalidomide
Mayo Clinic
2016 Phase 1 NCT02705638 United States;
METILPREDNISOLONE HIKMA - 1000 MG POLVERE PER SOLUZIONE INIETTABILE 10 FLACONCINI IN VETRO
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Mayo Interactive Breath Hold Monitor
Mayo Clinic
2006 - NCT00588367 United States;
Methionine
Saitama Medical University International Medical Center
2016 - JPRN-UMIN000019908 Japan;
Methylprednisolone
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
PARACETAMOLO NOVA ARGENTIA - 500 MG COMPRESSE 20 COMPRESSE
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
PREDNISONE DOC GENERICI - 5 MG COMPRESSE 30 COMPRESSE IN BLISTER PVC-PVDC/ALU
VIELABIO Inc.
2020 Phase 3 EUCTR2020-000417-33-IT Australia;Canada;China;France;Germany;Hungary;India;Israel;Italy;Japan;Korea, Republic of;Mexico;Netherlands;Poland;Spain;Sweden;Ukraine;United Kingdom;United States;
Perflubutane
Department of EndoscopyThe Jikei University School of Medicine
2018 - JPRN-UMIN000030735 Japan;
Prednisolone
Department of Gastroenterology, University of Tokyo
2010 - JPRN-UMIN000003804 Japan;
Osaka University
2016 - JPRN-UMIN000022633 Japan;
Prednisone
Chinese PLA General Hospital
2016 Phase 4 NCT02703194 China;
Katayama Sota
2021 Phase 3 JPRN-jRCT2071210001 Argentina;Australia;Canada;China;France;Germay;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;UK;USA;Ukraine;
National Institute of Allergy and Infectious Diseases (NIAID)
2021 Phase 2 NCT04918147 United States;
Peking Union Medical College Hospital
2012 Phase 2/Phase 3 NCT01758393 China;
Prednisone and Belimumab
Peking Union Medical College Hospital
2021 Phase 4 NCT04660565 China;
Prednisone and Mycophenolate mofetil
Peking Union Medical College Hospital
2015 Phase 2 NCT02458196 China;
Rilzabrutinib
Principia Biopharma, a Sanofi Company
2020 Phase 2 NCT04520451 Canada;United States;
Rituximab
Massachusetts General Hospital
2012 Phase 1/Phase 2 NCT01584388 United States;
Mayo Clinic
2016 Phase 1 NCT02705638 United States;
T 614
Wen Zhang
2017 Phase 4 NCT03368274 China;
Thalidomide
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
2020 Phase 4 ChiCTR2000028918 China;
Uplizna
Viela Bio, Inc.
2021 Phase 3 EUCTR2020-000417-33-SE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2021 Phase 3 EUCTR2020-000417-33-NL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-PL Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
2020 Phase 3 EUCTR2020-000417-33-DE Argentina;Australia;Canada;China;France;Germany;Hong Kong;Hungary;India;Ireland;Israel;Italy;Japan;Mexico;Netherlands;Poland;Spain;Sweden;Turkey;Ukraine;United Kingdom;United States;
XmAb5871
Xencor INC
2019 Phase 3 EUCTR2017-002214-31-IT Belgium;Canada;Czechia;France;Germany;Hungary;Israel;Italy;Netherlands;Poland;Spain;Sweden;United Kingdom;United States;
Xencor, Inc.
2016 Phase 2 NCT02725476 United States;
Zanubrutinib
Matthew C. Baker
2022 Phase 2 NCT04602598 United States;